A Two-Session Exposure Treatment and Parent Training for ARFID (ARFID-PTP)

University at Albany

Status: Enrolling

Conditions: Avoidant Restrictive Food Intake Disorder

Treatments: Behavioral: ARFID-PTP

Study type: Interventional

Funder types: Other

Identifiers

NCT04913194

21E001

Details and patient eligibility

About

This study aims to assess the acceptability, feasibility, and preliminary efficacy of a two-session, virtual parent-training exposure protocol for children ages 5-12 who experience picky eating consistent with an Avoidant-Restrictive Food Intake Disorder (ARFID) diagnosis.

Full description

Potential subjects aged 5 to 12 years with picky eating symptoms consistent with an ARFID diagnosis, as determined by the Pica, ARFID, Rumination Disorder Interview, a semi-structured diagnostic interview, will be recruited via social media and local doctor's offices. Eligible subjects will complete informed consent and an intake session. Participants will then be randomized to an immediate treatment group, in which they will begin treatment the following week, or a 4-week waitlist condition, in which they will wait four weeks to begin treatment. All participants will have the opportunity to receive the treatment, ARFID Parent Training Program or "ARFID-PTP." ARFID-PTP was adapted from a seven-session parent-training for extremely picky eating behaviors to examine the efficacy of a two-session, virtual protocol on increasing food intake and decreasing selective eating. The two virtual treatment sessions will include psychoeducation, parent-training skills, and exposure protocol. There will be 5 major assessment time points: intake, end of treatment, 4-weeks post-treatment, 3-months post-treatment, and 6-months post-treatment.

Enrollment: 40 estimated patients

Sex: All

Ages: 5 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children ages 5-12
• Child meets criteria for ARFID using the Pica, ARFID, Rumination Disorder Interview
• Established care with a primary care provider
• Not engaging in other medication or psychotherapy for ARFID during this treatment trial
• Fluently speak and read English

Exclusion criteria

• Child or parent experiencing suicidal thoughts
• Child or parent experiencing psychotic symptoms
• Child has a cognitive functioning disability

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Immediate Treatment

Experimental group

Description:

Participants in this arm will receive the intervention within 2 weeks of completing the intake session.

Treatment:

Behavioral: ARFID-PTP

Waitlist Control

Other group

Description:

Participants in this arm will not receive any intervention for two weeks. Participants will complete the treatment after 4-6 weeks of being on the waitlist after their intake session.

Treatment:

Behavioral: ARFID-PTP